Long non-coding RNA and tumor hypoxia: New players ushered toward an old arena

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Hypoxia is a classic feature of the tumor microenvironment with a profound impact on cancer progression and therapeutic response. Activation of complex hypoxia pathways orchestrated by the transcription factor HIF (hypoxia-inducible factor) contributes to aggressive phenotypes and metastasis in numerous cancers. Over the past few decades, exponentially growing research indicated the importance of the non-coding genome in hypoxic tumor regions. Recently, key roles of long non coding RNAs (lncRNAs) in hypoxia-driven cancer progression have begun to emerge. These hypoxia-responsive lncRNAs (HRLs) play pivotal roles in regulating hypoxic gene expression at chromatic, transcriptional, and post-transcriptional levels by acting as effectors of the indirect response to HIF or direct modulators of the HIF-transcriptional cascade. Notably, the aberrant expression of HRLs significantly correlates with poor outcomes in cancer patients, showing promise for future utility as a tumor marker or therapeutic target. Here we address the latest advances made toward understanding the functional relevance of HRLs, the involvement of these transcripts in hypoxia response and the underlying action mechanisms, highlighting their specific roles in HIF-1 signaling regulation and hypoxia-associated malignant transformation.

Original languageEnglish
Article number53
JournalJournal of Biomedical Science
Volume24
Issue number1
DOIs
Publication statusPublished - Aug 8 2017

Fingerprint

Long Noncoding RNA
Tumors
Hypoxia-Inducible Factor 1
Tumor Biomarkers
Gene expression
Modulators
Transcription Factors
Genes
Neoplasms
Chemical activation
Tumor Hypoxia
Hypoxia
Tumor Microenvironment

Keywords

  • Cancer
  • HIF-1α
  • HRL
  • Hypoxia
  • Hypoxia-responsive lncRNAs
  • lncRNA
  • Long non-coding RNA
  • Metastasis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

Long non-coding RNA and tumor hypoxia : New players ushered toward an old arena. / Shih, Jing Wen; Kung, Hsing Jien.

In: Journal of Biomedical Science, Vol. 24, No. 1, 53, 08.08.2017.

Research output: Contribution to journalReview article

@article{1f9df070a39043a7974f3a7564c5d5ef,
title = "Long non-coding RNA and tumor hypoxia: New players ushered toward an old arena",
abstract = "Hypoxia is a classic feature of the tumor microenvironment with a profound impact on cancer progression and therapeutic response. Activation of complex hypoxia pathways orchestrated by the transcription factor HIF (hypoxia-inducible factor) contributes to aggressive phenotypes and metastasis in numerous cancers. Over the past few decades, exponentially growing research indicated the importance of the non-coding genome in hypoxic tumor regions. Recently, key roles of long non coding RNAs (lncRNAs) in hypoxia-driven cancer progression have begun to emerge. These hypoxia-responsive lncRNAs (HRLs) play pivotal roles in regulating hypoxic gene expression at chromatic, transcriptional, and post-transcriptional levels by acting as effectors of the indirect response to HIF or direct modulators of the HIF-transcriptional cascade. Notably, the aberrant expression of HRLs significantly correlates with poor outcomes in cancer patients, showing promise for future utility as a tumor marker or therapeutic target. Here we address the latest advances made toward understanding the functional relevance of HRLs, the involvement of these transcripts in hypoxia response and the underlying action mechanisms, highlighting their specific roles in HIF-1 signaling regulation and hypoxia-associated malignant transformation.",
keywords = "Cancer, HIF-1α, HRL, Hypoxia, Hypoxia-responsive lncRNAs, lncRNA, Long non-coding RNA, Metastasis",
author = "Shih, {Jing Wen} and Kung, {Hsing Jien}",
year = "2017",
month = "8",
day = "8",
doi = "10.1186/s12929-017-0358-4",
language = "English",
volume = "24",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Long non-coding RNA and tumor hypoxia

T2 - New players ushered toward an old arena

AU - Shih, Jing Wen

AU - Kung, Hsing Jien

PY - 2017/8/8

Y1 - 2017/8/8

N2 - Hypoxia is a classic feature of the tumor microenvironment with a profound impact on cancer progression and therapeutic response. Activation of complex hypoxia pathways orchestrated by the transcription factor HIF (hypoxia-inducible factor) contributes to aggressive phenotypes and metastasis in numerous cancers. Over the past few decades, exponentially growing research indicated the importance of the non-coding genome in hypoxic tumor regions. Recently, key roles of long non coding RNAs (lncRNAs) in hypoxia-driven cancer progression have begun to emerge. These hypoxia-responsive lncRNAs (HRLs) play pivotal roles in regulating hypoxic gene expression at chromatic, transcriptional, and post-transcriptional levels by acting as effectors of the indirect response to HIF or direct modulators of the HIF-transcriptional cascade. Notably, the aberrant expression of HRLs significantly correlates with poor outcomes in cancer patients, showing promise for future utility as a tumor marker or therapeutic target. Here we address the latest advances made toward understanding the functional relevance of HRLs, the involvement of these transcripts in hypoxia response and the underlying action mechanisms, highlighting their specific roles in HIF-1 signaling regulation and hypoxia-associated malignant transformation.

AB - Hypoxia is a classic feature of the tumor microenvironment with a profound impact on cancer progression and therapeutic response. Activation of complex hypoxia pathways orchestrated by the transcription factor HIF (hypoxia-inducible factor) contributes to aggressive phenotypes and metastasis in numerous cancers. Over the past few decades, exponentially growing research indicated the importance of the non-coding genome in hypoxic tumor regions. Recently, key roles of long non coding RNAs (lncRNAs) in hypoxia-driven cancer progression have begun to emerge. These hypoxia-responsive lncRNAs (HRLs) play pivotal roles in regulating hypoxic gene expression at chromatic, transcriptional, and post-transcriptional levels by acting as effectors of the indirect response to HIF or direct modulators of the HIF-transcriptional cascade. Notably, the aberrant expression of HRLs significantly correlates with poor outcomes in cancer patients, showing promise for future utility as a tumor marker or therapeutic target. Here we address the latest advances made toward understanding the functional relevance of HRLs, the involvement of these transcripts in hypoxia response and the underlying action mechanisms, highlighting their specific roles in HIF-1 signaling regulation and hypoxia-associated malignant transformation.

KW - Cancer

KW - HIF-1α

KW - HRL

KW - Hypoxia

KW - Hypoxia-responsive lncRNAs

KW - lncRNA

KW - Long non-coding RNA

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=85026915253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026915253&partnerID=8YFLogxK

U2 - 10.1186/s12929-017-0358-4

DO - 10.1186/s12929-017-0358-4

M3 - Review article

C2 - 28789687

AN - SCOPUS:85026915253

VL - 24

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

M1 - 53

ER -